Literature DB >> 10749404

Role of tissue transglutaminase in celiac disease.

O Molberg1, S N McAdam, L M Sollid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10749404     DOI： 10.1097/00005176-200003000-00005

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  20 in total

1.  Prevalence and demographic characteristics of celiac disease among blood donors in Ribeirão Preto, State of São Paulo, Brazil.

Authors:  Suzeidi Bernardo Castanheira Melo; Maria Inez Machado Fernandes; Luiz Cesar Peres; Luiz Ernesto Almeida Troncon; Livia Carvalho Galvão
Journal:  Dig Dis Sci       Date:  2006-06-07       Impact factor: 3.199

2.  Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.

Authors:  Michael E Prime; Frederick A Brookfield; Stephen M Courtney; Simon Gaines; Richard W Marston; Osamu Ichihara; Marie Li; Darshan Vaidya; Helen Williams; Anna Pedret-Dunn; Laura Reed; Sabine Schaertl; Leticia Toledo-Sherman; Maria Beconi; Douglas Macdonald; Ignacio Muñoz-Sanjuan; Celia Dominguez; John Wityak
Journal:  ACS Med Chem Lett       Date:  2012-08-09       Impact factor: 4.345

Review 3.  Celiac disease--a worldwide problem.

Authors:  K Horvath; D I Mehta
Journal:  Indian J Pediatr       Date:  2000-10       Impact factor: 1.967

4.  SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.

Authors:  John Wityak; Michael E Prime; Frederick A Brookfield; Stephen M Courtney; Sayeh Erfan; Siw Johnsen; Peter D Johnson; Marie Li; Richard W Marston; Laura Reed; Darshan Vaidya; Sabine Schaertl; Anna Pedret-Dunn; Maria Beconi; Douglas Macdonald; Ignacio Muñoz-Sanjuan; Celia Dominguez
Journal:  ACS Med Chem Lett       Date:  2012-10-04       Impact factor: 4.345

5.  Enzymatic strategies to detoxify gluten: implications for celiac disease.

Authors:  Ivana Caputo; Marilena Lepretti; Stefania Martucciello; Carla Esposito
Journal:  Enzyme Res       Date:  2010-10-07

6.  Distribution of HLA class I alleles differs in celiac disease patients according to age of onset.

Authors:  Harald Vogelsang; Simon Panzer; Wolfgang R Mayr; Gerhard Granditsch; Gottfried F Fischer
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

7.  Immunohistochemical study of the apoptotic mechanisms in the intestinal mucosa during children's coeliac disease.

Authors:  Jirí Ehrmann; Antonín Kolek; Rostislav Kod'ousek; Jana Zapletalová; Sona Lísová; Paul Gerard Murray; Jirí Drábek; Zdenek Kolár
Journal:  Virchows Arch       Date:  2003-04-16       Impact factor: 4.064

8.  Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

Authors:  Jee Young Hwang; Lingegowda S Mangala; Jansina Y Fok; Yvonne G Lin; William M Merritt; Whitney A Spannuth; Alpa M Nick; Derek J Fiterman; Pablo E Vivas-Mejia; Michael T Deavers; Robert L Coleman; Gabriel Lopez-Berestein; Kapil Mehta; Anil K Sood
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

Review 9.  Transglutaminase 2 inhibitors and their therapeutic role in disease states.

Authors:  Matthew Siegel; Chaitan Khosla
Journal:  Pharmacol Ther       Date:  2007-05-13       Impact factor: 12.310

10.  Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ.

Authors:  C Esposito; F Paparo; I Caputo; M Rossi; M Maglio; D Sblattero; T Not; R Porta; S Auricchio; R Marzari; R Troncone
Journal:  Gut       Date:  2002-08       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.